Complete metabolic response to combined BRAF/MEK inhibition (dabrafenib-trametinib) in BRAF V600E-mutated metastatic parotid adenocarcinoma: A case report

Oral Oncology Reports · Elsevier

Аннотация

Publication date: September 2026 Source: Oral Oncology Reports, Volume 19 Author(s): Andy Kouanga, Marie-Justine Paillard, Thierry Nguyen, Christophe Borg

Читать у издателя →

Похожие статьи